Laboratory of Animal Applied Microbiology, Graduate School of Environmental and Life Science, Okayama University.
Department of Human Ecology, School of International Health, Graduate School of Medicine, The University of Tokyo.
Microbes Environ. 2021;36(2). doi: 10.1264/jsme2.ME21006.
IgA nephropathy is one of the leading causes of chronic kidney disease in Japan. Since the origin and mechanisms by which IgA nephropathy develops currently remain unclear, a confirmed disease diagnosis is currently only possible by highly invasive renal biopsy. With the background of the salivary microbiome as a rich source of biomarkers for systemic diseases, we herein primarily aimed to investigate the salivary microbiome as a tool for the non-invasive diagnosis of IgA nephropathy. In a comparison of salivary microbiome profiles using 16S rRNA amplicon sequencing, significant differences were observed in microbial diversity and richness between IgA nephropathy patients and healthy controls. Furthermore, recent studies reported that patients with IgA nephropathy are more likely to develop inflammatory bowel diseases and that chronic inflammation of the tonsils triggered the recurrence of IgA nephropathy. Therefore, we compared the salivary microbiome of IgA nephropathy patients with chronic tonsillitis and ulcerative colitis patients. By combining the genera selected by the random forest algorithm, we were able to distinguish IgA nephropathy from healthy controls with an area under the curve (AUC) of 0.90, from the ulcerative colitis group with AUC of 0.88, and from the chronic tonsillitis group with AUC of 0.70. Additionally, the genus Neisseria was common among the selected genera that facilitated the separation of the IgA nephropathy group from healthy controls and the chronic tonsillitis group. The present results indicate the potential of the salivary microbiome as a biomarker for the non-invasive diagnosis of IgA nephropathy.
IgA 肾病是日本慢性肾脏病的主要病因之一。由于 IgA 肾病的发病机制和起源目前仍不清楚,目前只能通过高度侵入性的肾活检来确诊。鉴于唾液微生物组是系统性疾病生物标志物的丰富来源,我们主要旨在研究唾液微生物组作为一种非侵入性诊断 IgA 肾病的工具。通过 16S rRNA 扩增子测序比较唾液微生物组图谱,发现 IgA 肾病患者和健康对照组之间的微生物多样性和丰富度存在显著差异。此外,最近的研究报告称,IgA 肾病患者更有可能发展为炎症性肠病,扁桃体的慢性炎症会引发 IgA 肾病的复发。因此,我们比较了 IgA 肾病患者、慢性扁桃体炎患者和溃疡性结肠炎患者的唾液微生物组。通过结合随机森林算法选择的属,我们能够以 0.90 的曲线下面积 (AUC) 将 IgA 肾病与健康对照组区分开来,以 0.88 的 AUC 将 IgA 肾病与溃疡性结肠炎组区分开来,以 0.70 的 AUC 将 IgA 肾病与慢性扁桃体炎组区分开来。此外,奈瑟菌属是有助于将 IgA 肾病组与健康对照组和慢性扁桃体炎组区分开的选定属之一。这些结果表明唾液微生物组作为 IgA 肾病非侵入性诊断的生物标志物具有潜力。